1. Home
  2. CXM vs EVO Comparison

CXM vs EVO Comparison

Compare CXM & EVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sprinklr Inc.

CXM

Sprinklr Inc.

HOLD

Current Price

$5.48

Market Cap

1.3B

Sector

Technology

ML Signal

HOLD

Logo Evotec SE

EVO

Evotec SE

HOLD

Current Price

$2.79

Market Cap

1.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CXM
EVO
Founded
2009
1993
Country
United States
Germany
Employees
N/A
4553
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.3B
1.0B
IPO Year
2021
N/A

Fundamental Metrics

Financial Performance
Metric
CXM
EVO
Price
$5.48
$2.79
Analyst Decision
Hold
Strong Buy
Analyst Count
8
1
Target Price
$8.28
$7.00
AVG Volume (30 Days)
3.7M
26.4K
Earning Date
06-03-2026
04-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.02
N/A
Revenue
$857,200,000.00
N/A
Revenue This Year
$2.52
$1.37
Revenue Next Year
$4.94
$10.05
P/E Ratio
$275.00
N/A
Revenue Growth
7.64
N/A
52 Week Low
$4.72
$2.31
52 Week High
$9.40
$4.42

Technical Indicators

Market Signals
Indicator
CXM
EVO
Relative Strength Index (RSI) 58.79 48.47
Support Level $5.14 $2.60
Resistance Level $5.60 $2.93
Average True Range (ATR) 0.19 0.07
MACD 0.05 0.02
Stochastic Oscillator 82.21 54.52

Price Performance

Historical Comparison
CXM
EVO

About CXM Sprinklr Inc.

Sprinklr Inc is engaged in enabling customer-facing teams, from Customer Service to Marketing, to collaborate across internal silos, communicate across digital channels, and leverage AI to deliver customer experiences at scale, all on one unified AI-based platform. It focuses on empowering companies to deliver next-generation, unified engagement journeys that reimagine the customer's experience. Its products include Sprinklr Service, Sprinklr Social, Sprinklr Insights, and Sprinklr Marketing. The company operates in the Americas, EMEA, and other countries. It derives maximum revenue from the Americas.

About EVO Evotec SE

Evotec SE is a life science company focused on developing pharmaceutical products through standalone services, integrated R&D programs, and strategic partnerships with pharmaceutical and biotechnology companies, academic institutions, and other partners. It operates across drug discovery, preclinical development, and manufacturing, with expertise in areas including oncology, central nervous system, cardiovascular-renal, immune and inflammatory, infectious, and other diseases. The Company generates revenue through fee-for-service and FTE-based services, milestones, and royalties, and equity ownership in biotechnology and academic projects. It operates through the Shared R&D and Discovery & Preclinical Development (D&PD) segments, with the majority of revenue generated from the USA.

Share on Social Networks: